| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Team Building > Business Innovation - Group Creativity |
|
Useful Advices - Business Innovation - Group Creativity
Creativity can be defined as problem identification and idea generation whilst innovation can be defined as idea select According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ion, development and commercialisation. There are other useful definitions in this field, for example, creativity can ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in be defined as consisting of a number of ideas, a number of diverse ideas and a number of novel ideas. There are distin lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ct processes that enhance problem identification and idea generation and, similarly, distinct processes that enhance id here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ea selection, development and commercialisation. Whilst there is no sure fire route to commercial success, these proces d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ses improve the probability that good ideas will be generated and selected and that investment in developing and commer ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc cialising those ideas will not be wasted. Group Creativity Effective group creativity results from managing easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi a number of different elements, some of which are: a) Group structure. Large and small groups, individual and pair com nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically binations produce variations of creative output. b) Motivation. Impacts the idea pool. c) Task structure. Sets start and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ and end points, establishes boundaries. Impacts creative output. d) Tacit knowledge. Making tacit knowledge explicit a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi d therefore tangible, useable and measurable. e) Creative and critical thinking. Producing and then editing. f) Idea ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a valuation. Effective idea selection allows resources to be concentrated on development and commercialisation. g) Netwo dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod rk management. Tapping into knowledge, overcoming competency traps, bridging. h) Culture. Creating a fostering environ cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ment. i) Depth versus breadth. Which is more productive, to master the literature of the field or to frame break into tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen other fields? j) Process. Qualitative research shows that people who regularly generate lots of ideas follow a similar t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel process, whether they know it or not. These and other topics are covered in depth in the MBA dissertation on Managing ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust Creativity & Innovation, which can be purchased (along with a Creativity and Innovation DIY Audit, Good Idea Generator y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products Software and Power Point Presentation) from http://www.man . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de aging-creativity.com/ You can also receive a regular, free newsletter by entering your email address at this site. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip You are free to reproduce this article as long as no changes are made and the author's name and site URL are retained tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Consider a Career as a Hypnotherapist How To Out-Market The Big Guys Are You Tele-Telling or Tele-Selling?
|